A carregar...
Improving CAR T Cell Therapy by Optimizing Critical Quality Attributes
Whether as a cure or bridge to transplant, chimeric antigen receptor (CAR)-T cell therapies have shown dramatic outcomes for the treatment of hematologic malignancies, and particularly relapsed/refractory B cell leukemia and lymphoma. However, these therapies are not effective for all patients, and...
Na minha lista:
| Publicado no: | Semin Hematol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7518470/ https://ncbi.nlm.nih.gov/pubmed/32892841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2020.07.005 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|